ADMA: Rega marang dodolan ADMA Biologics Inc
Active recruitment of biochemists and the retention of R&D staff confirm that ADMA Biologics is in an expansion phase. The price-to-sales ratio dynamics reflect investor reaction, with the parameter stabilizing at 5.70. Growth is supported by a closed-loop immunoglobulin production cycle and AI-driven plasma purification robotics, which minimize human error and guarantee drug sterility.
Rincian analitis perusahaan ADMA Bio (ADMA)
- rega saham lan target rega konsensus:
- informasi kapitalisasi pasar:
- data nilai buku modal saham:
- statistik kawajiban utang lan likuiditas:
Rasio Total Utang marang Ekuitas ADMA Biologics|ADMA - Utang jangka dawa marang modal|Utang jangka cendhak marang modal ADMA Corp|ADMA - Gunggung utang perusahaan|Rasio utang marang aset resik ADMA Bio|ADMA - Utang jangka dawa perusahaan|Utang jangka cendhak perusahaan ADMA Biologics|Koefisien jangkoan perantara admabiologics.com
- indikator profitabilitas perusahaan lan kelipatan valuasi:
ADMA - Bathi resik perusahaan|Bathi resik sing dikarepake ADMA Biologics|ADMA - Rasio rega marang bathi|Rega marang bathi mangsa ngarep ADMA Biologics Inc|ADMA - Rasio rega marang bathi tumrap wutah|Nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan ADMA Bio|ADMA - Bathi operasional EBITDA|Bathi resik saben saham sajroning taun lumaku ADMA Biologics|ADMA - Bathi resik saben saham (EPS TTM)|Owah-owahan bathi resik saben saham taun-ka-taun sajrone rolas wulan pungkasan admabiologics.com|ADMA - Wutah bathi ing taun lumaku|Prakiraan wutah bathi saben saham kanggo taun ngarep ADMA Biologics
- rincian pendapatan lan dodolan emiten:
Ringkesan analitik perusahaan:admabiologics.com, ADMA
The P/S ratio determines the market value of one dollar of revenue, allowing an investor to assess the degree of overpayment for a business before deducting expenses. By analyzing the price-to-sales valuation, one can understand the extent to which the market awards a premium to ADMA Biologics (ADMA) for its technological leadership in immunoglobulin synthesis and unique drug screening methods for immunodeficient patients.
Perusahaan pesaing
argenx.com - Rasio kapitalisasi marang pendapatan|Multiplikator P/S BNTX (BioNTech)|Abivax Pharma (ABVX) - Rega marang dodolan|Protagonist Therapeutics Inc - Multiplikator P/S|IMVT - Multiplikator P/S|KNSA: Multiplikator P/S|Rasio kapitalisasi marang pendapatan GRFS|Rasio rega marang pendapatan Adaptive Biotechnologies Corporation|Kapitalisasi marang pendapatan Celldex Therapeutics Inc (CLDX)|Multiplikator P/S AUPH|Multiplikator P/S BioCryst Corp (BCRX)|Vera Therapeutics, Inc. - Kapitalisasi marang pendapatan|Rasio kapitalisasi pasar marang pendapatan DNTH|Pharvaris - Multiplikator P/S|ABCL: Rasio rega marang pendapatan|TRML: Multiplikator P/S|PGEN - Koefisien rega marang pendapatan|Rasio rega marang pendapatan Pharming Group N.V.|Rega marang dodolan nektar.com NKTR|Rasio rega marang pendapatan Upstream Bio (UPB)|Rasio rega marang pendapatan ZBIO (Zenas Bio)|Rasio rega marang pendapatan Immunome Corp IMNM|Gossamer Bio Corp. (GOSS) - Rega marang dodolan|KalVista Pharmaceuticals - Multiplikator P/S|Multiplikator rega marang pendapatan septerna.com (SEPN)|PVLA: Multiplikator P/S|SVRA - Koefisien rega marang pendapatan|RIGL (Rigel Pharmaceuticals Inc) - Multiplikator P/S|Kapitalisasi marang pendapatan AnaptysBio Inc. (ANAB)|Rasio rega marang pendapatan Astria Therapeutics (ATXS)|Koefisien rega marang pendapatan engene.com|Multiplikator P/S RAPT (RAPT Therapeutics)|Multiplikator P/S Aerovate Therapeutics, Inc. JBIO|Aclaris - Multiplikator P/S|KYTX (Kyverna Therapeutics, Inc) - Rasio kapitalisasi marang pendapatan|Tiziana Life Sciences (TLSA) - Rasio rega marang pendapatan|Kapitalisasi marang pendapatan cabalettabio.com|VTYX (Ventyx Biosciences, Inc.) - Multiplikator P/S|Multiplikator P/S Theratechnologies, Inc.|Rasio rega marang pendapatan Avalo Therapeutics Inc. (AVTX)|ELDN: Rasio rega marang dodolan|Multiplikator P/S AGEN (Agenus)|Rasio kapitalisasi pasar marang pendapatan CLYM|Zura Bio - Multiplikator P/S|ATYR - Multiplikator P/S|adagene.com (ADAG) - Rasio rega marang pendapatan|Ikena Oncology - Rasio kapitalisasi pasar marang pendapatan|Rasio rega marang pendapatan Shattuck Labs Inc|Kapitalisasi marang pendapatan Equillium Bio (EQ)|Multiplikator P/S CNTB|Multiplikator P/S immunic-therapeutics.com (IMUX)|Atara Bio - Kapitalisasi marang pendapatan|Rasio kapitalisasi pasar marang pendapatan IFRX|X4 Pharmaceuticals - Multiplikator P/S|Koefisien rega marang pendapatan Adicet Bio ACET|celularity.com (CELU) - Rasio rega marang pendapatan|Kapitalisasi marang pendapatan INmune Bio Inc|Rasio rega marang pendapatan Barinthus Bio|Kapitalisasi marang pendapatan Kezar Life Sciences Inc (KZR)|Kapitalisasi marang pendapatan SABS (SAB Biotherapeutics)|Multiplikator P/S akaritx.com (AKTX)|Rasio rega marang pendapatan Enlivex Therapeutics Ltd. ENLV|QTTB: Rasio kapitalisasi marang pendapatan|GeoVax Labs Inc - Multiplikator P/S|Rega marang dodolan Edesa Biotech Corp|IBIO: Multiplikator P/S|Carisma Therapeutics Inc. (CARM) - Multiplikator P/S|XTLB (XTL Biopharmaceuticals Ltd.) - Multiplikator P/S|Rasio kapitalisasi marang pendapatan BOLT (Bolt Bio)|Rasio rega marang pendapatan HCW Biologics Inc. (HCWB)|Kapitalisasi marang pendapatan aptevotherapeutics.com APVO|Multiplikator P/S AIM (AIM ImmunoTech Inc.)|Multiplikator P/S Aditxt Inc. ADTX|GRI: Kapitalisasi marang pendapatan|Rasio kapitalisasi pasar marang pendapatan XRTX (XORTX Therapeutics Inc)|HIND: Multiplikator P/S|REVB (Revelation Biosciences Corp) - Rasio rega marang pendapatan|INDP (Indaptus Therapeutics) - Multiplikator P/S|scinai.com (SCNI) - Koefisien rega marang pendapatan|Rasio rega marang pendapatan CalciMedica, Inc. (CALI)|AFMD - Rega marang dodolan|Rasio rega marang pendapatan Allakos ALLK|HOOKIPA Pharma, Inc. - Rasio rega marang pendapatan|IGMS - Rasio rega marang pendapatan|Rega marang dodolan iteostherapeutics.com|OCEA: Multiplikator P/S|Multiplikator rega marang pendapatan TC BioPharm (Holdings) Plc TCBP|THRD (Third Harmonic Bio, Inc) - Multiplikator P/S
